Mutation in Mg-Protoporphyrin IX Monomethyl Ester Cyclase Decreases Photosynthesis Capacity in Rice by Xuexia Wang (3701098)

“…Chlorophyll content decreases 43–51% and the granal stacks of chloroplasts becomes thinner in <i>m167</i>. …”

Decreased Patrolling Efficiency and Decreased ConA Hepatitis Severity in CXCR6-Deficient Mice by Frederic Geissmann (75)

“…<div><p>(A) Serum transaminase levels in <i>cxcr6^gfp/gfp</i>, <i>cxcr6^gfp/+</i>, and <i>cxcr6^+/+</i> littermates 12 h after a challenge with 20 mg/kg ConA IP. …”

SFN decreased MMP-2 expression and activity in U87MG and U373MG cells. by Chunliu Li (284115)

“…<p>(A) SFN decreased MMP-2 expression via activated ERK1/2. We treated the cells with SFN (20 µM) without or with PD98059 (25 µM) for 24 h. …”

Decreased ShcA expression promotes EMT in NMuMG and HaCaT cells. by Baby Periyanayaki Muthusamy (838234)

“…<p>(A) ShcA levels, assessed by immunoblotting, in NMuMG and HaCaT cells transfected with ShcA or control siRNA. siShc-a and siShc-b are ShcA siRNAs used in NMuMG cells, and siShc-c and siShc-d are used in HaCaT cells. …”

Trial profile. by Chanel Avenant (409756)

“…The open-label WHICH clinical trial, conducted at two sites in South Africa from 2018–2019, randomized HIV-negative women aged 18–40 years to 150 mg DMPA-IM 12-weekly (n = 262) or 200 mg NET-EN 8-weekly (n = 259). We measured testosterone by UHPLC-MS/MS and SHBG by immunoassay in matched pairs of serum samples collected at baseline (D0) and at peak serum progestin levels at 25 weeks post initiation (25W) (n = 214–218 pairs). …”

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons by Jiacheng Ma (1530640)

“…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …”

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons by Jiacheng Ma (1530640)

“…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …”

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons by Jiacheng Ma (1530640)

“…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …”

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons by Jiacheng Ma (1530640)

“…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …”

Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons by Jiacheng Ma (1530640)

“…We have previously demonstrated that modulating molecular chaperones with KU-32, a novobiocin derivative, ameliorates physiologic and bioenergetic deficits of diabetic peripheral neuropathy (DPN). …”

Data_Sheet_1_Switching to second line MS disease-modifying therapies is associated with decreased relapse rate.PDF by James John Marriott (16935942)

Modafinil decreased EEG amplitude in the synchronized model. by Chang-Rui Chen (467755)

Pretreatment with terazosin (0.5, 1 mg/kg) reversed the decrease in EEG amplitude produced by modafinil (90 mg/kg, i.p.). by Chang-Rui Chen (467755)

“…The increase in EEG amplitude may be interpreted as synchronization and a decrease in EEG can be interpreted as a desynchronization. …”

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Pim overexpression increases and Pim inhibition by DHPCC-9 decreases growth of orthotopic prostate xenografts. by Niina M. Santio (279874)

Long-term treatment with rapamycin results in decrease in progenitor cells. by Zhenya Lu (780517)

“…Quantitative calculation of DCX-positive cells per field in different groups. Rats treated with 1.0 and 3.0 mg/kg rapamycin demonstrated decrease in DCX-positive cells. …”

Regions of significantly decreased ACM of SP-MS relative to RR-MS patients. by Mark Lyksborg (583318)

Decreased abundance of Rab10 in a vesicular membrane fraction. by Scott M. Vanderwerf (785324)

Long-term treatment with rapamycin results in decrease in cellular immune factors. by Zhenya Lu (780517)

“…No obvious change was noted among different groups in Il-1β both in brain and blood (A,B). IL-2 was decreased with 1.0 and 3.0 mg/kg rapamycin treatment both in brain and blood (C, D). …”